Postmastectomy radiotherapy: an American society of clinical oncology, American society for radiation oncology, and society of surgical oncology focused guideline …

A Recht, EA Comen, RE Fine, GF Fleming… - Journal of Clinical …, 2016 - ascopubs.org
Purpose A joint American Society of Clinical Oncology, American Society for Radiation
Oncology, and Society of Surgical Oncology panel convened to develop a focused update of …

The prognosis comparison of different molecular subtypes of breast tumors after radiotherapy and the intrinsic reasons for their distinct radiosensitivity

L He, Y Lv, Y Song, B Zhang - Cancer management and research, 2019 - Taylor & Francis
Radiotherapy can increase the cell cycle arrest that promotes apoptosis, reduces the risk of
tumor recurrence and has become an irreplaceable component of systematic treatment for …

The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation

C Shah, F Vicini, SF Shaitelman, J Hepel, M Keisch… - Brachytherapy, 2018 - Elsevier
Purpose Adjuvant radiation after breast-conserving surgery remains the standard-of-care
treatment for patients with ductal carcinoma in situ and early-stage invasive breast cancer …

Inhibition mechanism of acellular dermal matrix on capsule formation in expander–implant breast reconstruction after postmastectomy radiotherapy

IK Kim, SO Park, H Chang, US Jin - Annals of Surgical Oncology, 2018 - Springer
Background Capsular contracture is one of the most common complications of expander–
implant breast reconstruction. Recently, clinical reports have shown that use of an acellular …

Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial

YH Zeidan, JG Habib, L Ameye, M Paesmans… - International Journal of …, 2018 - Elsevier
Purpose To analyze the impact of postmastectomy radiation therapy (PMRT) for patients with
T1-T2 tumors and 1 to 3 positive lymph nodes enrolled on the Breast International Group …

Breast cancer biology: clinical implications for breast radiation therapy

JK Horton, R Jagsi, WA Woodward, A Ho - International Journal of …, 2018 - Elsevier
Historically, prognosis and treatment decision making for breast cancer patients have been
dictated by the anatomic extent of tumor spread. However, in recent years,“breast cancer” …

Local–regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)

JR Bellon, H Guo, WT Barry, CT Dang… - Breast cancer research …, 2019 - Springer
Purpose Women with HER2-positive breast cancer treated prior to effective anti-HER2
therapy have higher rates of local–regional recurrence (LRR) than those with HER2 …

The value of adjuvant radiotherapy on survival and recurrence in triple-negative breast cancer: A systematic review and meta-analysis of 5507 patients

MA O'Rorke, LJ Murray, JS Brand… - Cancer treatment reviews, 2016 - Elsevier
Background The value of adjuvant radiotherapy in triple negative breast cancer (TNBC)
remains unclear. A systematic review and meta-analysis was conducted in TNBC patients to …

Tailoring the omission of radiotherapy for early-stage breast cancer based on tumor biology

SG Allen, C Speers, R Jagsi - Seminars in radiation oncology, 2022 - Elsevier
Advances in our understanding of tumor biology now permit greater personalization of
radiotherapy for early-stage breast cancer. De-escalation of radiotherapy is an important …

Post-mastectomy radiation therapy in HER-2 positive breast cancer after primary systemic therapy: Pooled analysis of TRYPHAENA and NeoSphere trials

O Saifi, B Bachir, J Panoff, P Poortmans… - Radiotherapy and …, 2023 - Elsevier
Purpose The role of post-mastectomy radiation therapy (PMRT) following primary systemic
therapy (PST) in HER-2 positive breast cancer (Her2+ BC) remains poorly understood. The …